Recommended Global Pharmaceutical Sciences Conferences
Pharmaceutical Sciences 2019
Following the tradition of successful Congresses held in several European countries, Dubai, Spain, Italy, India, South Africa and USA, the Organizing Committee of ConferenceSeries Ltd is pleased to invite all the participants across the globe to attend the 19th world Congress on Pharmaceutical Sciences and Innovations in Pharma Industry slated on February 25- 26, 2019 at Berlin, Germany.
The conference is a specially organized two day event which will provide a multi-channel communication platform that brings together both “producers” and “consumers” of pharma world of generic sector. It includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. It is a perfect platform for researchers, scientists and, delegates to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.
Motives to attend:
- Keynote presentation along with interactions to galvanize the scientific community.
- Workshop and symposiums to reach the largest assemblage of participants from the Pharma community.
- A wide track of exhibitors to showcase the new and emerging technologies.
- Platform to global investment community to connect with stakeholders in Pharma sector.
- Young Scientist/ Investigators Award geared towards best budding young research.
- Links to the political marketing resources in order to expand your business and research network.
- Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.
- Scholars from Pharmaceutical backgrounds
- Researchers from Pharmaceutical Companies, Pharmacy Associations and Societies
- Health professionals
- Business development professionals, Consultants and Pharma service providers
- Quality control specialist
- Graduates and post graduates in industrial pharmacy
- Medical Devices Manufacturing Companies, CRO
- Data Management Companies.
- Pharmaceutical legislators and regulators
Past Conference Statistics:
Globalized growth of Pharmaceutical Research
Pharmaceuticals are one of the world's most beneficial ventures. In 2008 alone, the pharmaceutical business sold $773 billion in items around the world a number that has reliably developed for as long as 8 years and is anticipated to increment again by 2.5 to 3.5 percent in 2017, as per the medication statistical surveying firm IMS Health.
In any case, the procedure that transforms look into dollars into pharmaceuticals is a moderate and regularly strenuous one. It now takes a normal of 12 to 15 years and up to $1.7 billion for a medication to go from revelation to advertise, as indicated by The Pharmaceutical Research and Manufacturers of America. Also, regardless of constantly and cash contributed, just a modest bunch of medications are affirmed by the FDA every year.
The laborious medication endorsement prepare uncovers a focal truth about Big Pharma: it's a standout amongst the most seriously controlled businesses on the planet. The U.S. Nourishment and Drug Administration (FDA) and its European Union partner, the European Medicines Agency (EMEA), represent each part of a medication's improvement from chemicals utilized as a part of the medication and clinical study directions, called conventions, to bundling segments and showcasing materials. This strict oversight is intended to ensure persistent wellbeing, and pharma organizations consider administrative oversight important. The consistent weight to hold fast to government commands shapes each part of a pharma company's association, operations, and culture. For instance, sedate organizations keep up capable administrative undertakings divisions-the offices that arrangement with government offices and they have a tendency to be hazard disinclined.
The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing. There are few trends which are reshaping the marketplace.
Escalating demand for medicines
The global pharmaceutical market is growing steadily, with sales reaching $1.08 trillion in 2011 – a year-on-year increase of 7.8%. The mature economies proved very sluggish, but the growth economies were another matter. Sales in the BRIC countries (Brazil, China, India and Russia) rose by 22.6%, while sales in the other 13 growth countries (the ‘fast followers’, as we call them) rose by 7.2%.9 If this pattern continues, the market for medicines could be worth nearly $1.6 trillion by 2020. 10 Indeed, it could be worth even more. Demand for pharma’s products is rising dramatically, as the global population increases, ages and becomes more sedentary. In 2010, there were an estimated 6.9 billion people. By 2020, there will be more than 7.6 billion.11 And, if present trends are any guide, many of them will have health problems In short, there are more people – and more sick or elderly people – in the world today than ever before. More people have access to affordable healthcare than ever before. And, by 2020, access to healthcare may well be regarded everywhere as a basic human right.
Poor scientific productivity
Take the vexed issue of the industry’s scientific productivity. Although the number of new medicines reaching the market picked up in 2011, pharma’s annual output has effectively flat lined for the past 10 years . Developing new medicines is becoming an increasingly expensive business, too, although precisely how expensive is the subject of fierce debate. In 2006, the Tufts Center for the Study of Drug Development put average costs per molecule at $1.24-1.32 billion.22 Various commentators have since challenged these figures, claiming that the real cost is anything from $75 million to $4 billion, although most people lean towards the higher end of the range.
So where does the pharma industry now stand? It’s proved remarkably resilient, given the many problems it’s dealing with. But, in essence, it faces two overarching challenges. Tomorrow’s challenge is to develop new medicines that can prevent or cure currently incurable diseases. Today’s challenge is to get to tomorrow – and that’s a tall order in itself. Fortunately, there are a number of steps senior executives can take to help their companies reach 2020 and ready them for the opportunities the next decade brings.
Major Pharmaceutical Associations & Societies in Europe :
Past Conference Report
Pharmaceutical Sciences 2018
Conference Series hosted the 12th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry at Park Inn by Radisson London Heathrow, UK during February 26-27, 2018.The conference was designed around the theme of “Latest Trends in Pharmacy : Spanning the Gap in Research and Product Commercialization” and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering. Moreover, the networking sessions laid the foundation for some time worthy collaborations between many start-up and big industries. The post conference networking lunch session witnessed a number of B2B meetings that are turning up to be mutually beneficial to both the organizations who had gone in for the business meetings.
Pharmaceutical Sciences 2018 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Pharma Industry and Pharma Sciences. This congress not only brought forward the latest developments in the field but also provided solutions to the numerous challenges encountered in developing a Pharma Industry.
Conference Series would like to convey a warm gratitude to all the Honorable guests, Keynote Speakers, Delegates, Media Partners and Exhibitors for their participation in Pharmaceutical Sciences 2018.
Eric Dybeck, Pfizer Global Research and Development, USA
Margaret Shine, SRL Research, Ireland
Poupak Fallahi, University of Pisa, Italy
Zeeshan Ahmad, De Montfort University, UK
Paula Wood, Human Factors, UK
Simon Raymond, Melbourne University, Australia
Vera Matta, Sweet Diet Clinic, Lebanon
Krzysztof Wrzesinski, CelVivo IVS, Denmark
Mohammad Bagher Rezaee, Research Institute of Forest and Rangeland, Iran
We on behalf of the conference specially thank the exhibitors for their participation in the congress and also the media partners for their wonderful marketing of the event. Conference Series also took the privilege of felicitating Pharmaceutical Sciences 2018 Organizing Committee, Keynote Speakers, Chair and Co-Chairs whose support made conference a great success.
With the enormous feedback from the participants and supporters of Pharmaceutical Sciences 2017, we are glad to announce 19th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry during February 25- 26, 2019 at Berlin, Germany.
Past Reports Proceedings Gallery